Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.49M | 22.49M | 50.87M | 39.78M | 45.56M |
| Total Depreciation and Amortization | 5.97M | 7.43M | 5.97M | 5.97M | 5.97M |
| Total Amortization of Deferred Charges | 151.00K | 157.00K | 161.00K | 163.00K | 166.00K |
| Total Other Non-Cash Items | 38.79M | 22.04M | 21.60M | 19.92M | 8.16M |
| Change in Net Operating Assets | -49.63M | 74.04M | 30.14M | 13.50M | -25.86M |
| Cash from Operations | 27.76M | 126.15M | 108.73M | 79.33M | 33.99M |
| Capital Expenditure | -- | -107.00K | -71.00K | -4.00K | -128.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -183.65M | -17.53M | -4.72M | -19.59M | 2.49M |
| Cash from Investing | -183.65M | -17.63M | -4.79M | -19.59M | 2.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00M | -5.00M | -3.75M | -3.75M | -3.75M |
| Issuance of Common Stock | 347.00K | 2.65M | 754.00K | 2.10M | 4.71M |
| Repurchase of Common Stock | -2.57M | -663.00K | 0.00 | -1.03M | -1.31M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -7.22M | -3.02M | -3.00M | -2.69M | -352.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.10M | 105.50M | 100.95M | 57.05M | 36.00M |